Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation.

A challenging case of facial oedemas revealing a systemic peripheral T-cell lymphoma, not otherwise specified.

Reliability of durometry to assess firmness of calcinosis lesions in Juvenile and adult dermatomyositis.

Distinct Interferon and Intracellular Signaling Signatures in Systemic Lupus Erythematosus and Dermatomyositis by Integrative Transcriptomic and Proteomic Analysis.

Adverse pregnancy outcomes in adult patients with idiopathic inflammatory myopathy: a systematic review and meta-analysis.

Clinical Findings, Antibody Panel and Pathology of Patients with Inflammatory Myopathies in Isfahan Province, Iran.

Relapse of Juvenile Dermatomyositis following Eight Years in Remission: A Case Report.

Prevalence and Risk of Falls and Fractures in the Idiopathic Inflammatory Myopathies: A Cross-Sectional Study of 470 Patients.

Severe Juvenile Dermatomyositis With Peripheral Nervous System Involvement: A Case Report.

Semi-quantitative analyses of muscle magnetic resonance imaging for pattern recognition in early idiopathic inflammatory myopathies.

The role of extracorporeal membrane oxygenation in the management of rapidly progressive interstitial lung disease due to anti-melanoma differentiation-associated gene 5 antibody dermatomyositis: A case series and brief literature review.

Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum.

Checkerboard Hyperkeratosis With Apoptotic Keratinocytes as Features of Mechanic's Hands and Review of the Literature.

Degos-Like-Skin Lesions in the Setting of Dermatomyositis: A Case Series and Literature Review.

A Study of Cutaneous Manifestations in Patients During the Post-COVID Period in A Tertiary Care Center.

Diagnosis of a patient with pulmonary and skeletal cryptococcosis: A case report and literature review.

Fatal Cardiomyopathy Secondary to Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report.

Palmar Cutaneous Erythematous Macules: A Case Report of an Atypical Presentation of Chilblain Lupus Erythematosus.

"The Cancer that Carried the Chalk"-NXP2+ Paraneoplastic Dermatomyositis Unleashing Calcinosis Cutis and Peripheral Neuropathy.

Elevated Serum Levels of β1,4-Galactosyltransferase 1 Have Diagnostic Value in Patients With Dermatomyositis.

Immune dysregulation and infection susceptibility in Anti-MDA5 dermatomyositis.

Linear and streaky rash in a young female.

Anti-PM/Scl Antibody-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease in a 19-Year-Old Male: Clinical Implications of a Presumptive Diagnosis Based on Line Immunoassay Positivity.

Association of diagnostic delay with disease activity and cumulative damage in Hispanic patients with idiopathic inflammatory myopathies: a cross-sectional study.

Global landscape of juvenile dermatomyositis research: a bibliometric analysis.

Clinical Value of Bronchiectasis and Airspace Enlargement Depicted on Iodine Map in Patients With Interstitial Lung Disease: A Pilot Study.

Comprehensive Analysis Reveals Potential Molecular Targets in Juvenile Dermatomyositis.

Evaluating the value of lactic dehydrogenase in anti-MDA5-positive Dermatomyositis associated with interstitial lung disease.

A case of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with a challenging diagnosis due to the absence of typical skin manifestations.

Cooccurrence of Anterior Cruciate Ligament Rupture and Ganglion Cyst: Clinical Complexity and Ultrasound-Guided Tailored Management.

Amyopathic dermatomyositis associated with anti-MDA5 antibodies and rapidly progressive interstitial pneumonia: 2 cases with different clinical evolution.

Parallel course of calcinosis and cancer in a patient with anti-NXP2-positive dermatomyositis: A case report.

Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositis.

Dermatomyositis masquerading as angioedema: a crucial differential not to overlook.

Recurrent anti-TIF1γ-positive dermatomyositis coexisting with postoperative parotid lymphoepithelial carcinoma: a case report with pathogenesis analysis.

Flagellate erythema and breast infiltration.

Overfitting, sparse data bias, and variable selection in the predictive model for rapidly progressive interstitial lung disease in dermatomyositis.

Evaluating the Diagnostic Potential of Myxovirus Resistance Protein 1 (MX1) and Myxovirus Resistance Protein 2 (MX2) As Biomarkers in Idiopathic Inflammatory Myopathies.

Dermatomyositis: Prevalence, Clinical Spectrum, Diagnostic Approach, and Management Strategies.

Nailfold video capillaroscopy as a non-invasive biomarker in juvenile dermatomyositis: A longitudinal analysis of microvascular changes and clinical relevance over one year.

Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission.

Periorbital heliotrope erythema with edema as a potential clinical marker of paraneoplastic Dermatomyositis - a case series.

Distinct by Design: Unraveling the Unique Clinical and Transcriptomic Identity of Juvenile Scleromyositis Overlap Compared to Juvenile Systemic Sclerosis and Juvenile Dermatomyositis: Implications for Care and Pathogenesis.

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies.

Clinical features, treatment, and outcomes of anti-PD-1/PD-L1 immune checkpoint inhibitors induced dermatomyositis.

Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype.

Fitbit as an activity monitor in idiopathic inflammatory myopathy: results from a real-world cohort.

Neutrophil-to-lymphocyte ratio as a prognostic indicator in anti-MDA5 dermatomyositis with interstitial lung disease and its link to IFN-α and IL-6.

Acquired generalised lipodystrophy as an uncommon complication of anti-Mi-2 dermatomyositis: a case report.

Temporal Dissociation Between Clinical Remission and Microvascular Improvement Assessed by AI-Assisted Capillaroscopy in Anti-Mi-2 Dermatomyositis: Potential Therapeutic Implications.

A Case of Anti-SAE Antibody-Positive Dermatomyositis Coexisting With Sjögren's Disease.

Genetic Whispers in Hyperphosphataemic: Tumor Calcinosis in a 30-year-old.

Improved Detection of Myositis-Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison with Line Blot and Conventional Immunoprecipitation.

Long-term management challenges in postmyopathic dermatomyositis.

Erythematous rash and proximal muscle weakness in a 59-year-old woman: Delayed diagnosis of dermatomyositis in a patient with skin of color.

Development and validation of a multi-institutional electronic juvenile idiopathic arthritis phenotype.

Association between Oropharyngeal Dysphagia and Subgroups of Patients with Idiopathic Inflammatory Myopathy: A Cross-Sectional Study.

The efficacy of transbronchial lung cryobiopsy for chronic progressive changes after remission of anti-MDA5 antibody-positive interstitial lung disease: a report of two cases.

Anti-MDA5 monoclonal antibodies from patients with dermatomyositis - B cell characteristics and differential targeting of the helicase domains.

Atypical dermatomyositis with positive anti-nuclear matrix protein 2 antibodies complicated by rhabdomyolysis syndrome: a case report and literature review.

Pretreatment Cytokine Signatures as Candidate Biomarkers for JAK Inhibitor Response in Anti-MDA5 Dermatomyositis-Related Interstitial Lung Disease: A Pilot Study.

Elevated serum interleukin-38 levels in polymyositis and dermatomyositis: diagnostic implications and correlations with inflammatory markers.

Interferon-Driven Tryptophan Metabolism Links Inflammation and Mental Health in Juvenile Dermatomyositis.

Acute muscle injury and subcutaneous edema in a patient with anti-nuclear matrix protein-2 antibody positive dermatomyositis sine dermatitis: A Case Report.

Complement activation and M2-like macrophage accumulation in anti-MDA5 monoclonal antibody-induced hepatic injury in mice.

Anti-MDA5 Antibody-Positive Dermatomyositis in Emirati Patients: A Case Series Highlighting Clinical Variability.

A case study of delayed-diagnosed leprosy: advancing diagnosis through MetaPath.

How loss-of-function mutations in IFIH1 contribute to infectious and/or inflammatory disease - a systematic review.

Anti-SAE Antibody-Positive Dermatomyositis Presenting With Widespread Erythema Complicated by Rosai-Dorfman Disease.

Prognostic value of HRCT-based risk stratification for acute/subacute progression in polymyositis/dermatomyositis-associated interstitial lung disease.

Postpartum-Onset Dermatomyositis Presenting With Malignant Pleural Effusion: A Case Report.

Calcinosis Cutis Universalis: A Review of Therapeutic Strategies and Surgical Management.

Distinct anti-MDA5 antibody trajectories associated with long-term outcomes in 6-month survivors of anti-MDA5 dermatomyositis with interstitial lung disease.

Validation of simplified scoring systems for assessing cutaneous disease activity in dermatomyositis.

Presence of Multiple Muscle Specific Autoantibodies (MSAs) in a Young Child with Juvenile Dermatomyositis.

Detection of dermatomyositis skin rashes in skin of color: Addressing critical training gaps.

Multicentre development and validation of data-driven claims-based algorithms for identifying dermatomyositis and polymyositis in Japan.

Dermatomyositis Mimicking Statin-Induced Myopathy in A 62-Year-Old Woman.

Integrated proteomic and transcriptomic profiles reveals the role of OAS3 in dermatomyositis pathogenesis.

Monocyte-driven vasculopathy distinguishes dermatomyositis from CLE.

Early detection and intervention in dermatomyositis: current evidence and clinical implications.

Development of enzyme-linked immunosorbent assays for the detection of myositis-specific autoantibodies against signal recognition particle, nuclear matrix protein 2, and small ubiquitin-like modifier activating enzyme.

Elbow Gottron's Sign as a Predictor of Dermatomyositis With Respiratory System as the Initial Manifestation: A Retrospective Study.

Cytomegalovirus DNAemia in patients with anti-melanoma differentiation-associated gene 5 positive dermatomyositis from southern China.

Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Lung Disease, Induced by Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Carcinoma.

Lung Involvement in MDA5-Positive Juvenile Dermatomyositis: A Case of Misdiagnosed Pneumonia in a Toddler.

Identifying cutaneous dermatomyositis disease area and severity index thresholds of disease severity in alignment with patient perspectives on quality of life: A retrospective analysis.

Pulmonary alveolar proteinosis developing during tofacitinib treatment for anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease: a case report and review of the literature.

Critical illness with fatal muscle weakness and gastrointestinal perforation after COVID-19.

Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Proteomic profiles in inclusion body myositis and polymyositis with mitochondrial pathology.

Clinically validated assay for rapid determination of type I and type II interferon activity in systemic inflammatory diseases.

Identification of common genes and biomarkers between Dermatomyositis and rheumatoid arthritis through integrated bioinformatics.

Atypical Interplay of Dermatomyositis, Metastatic Caecal Carcinoma, and Connective Tissue Disease.

[Expression of the melanoma 2-mediated pyroptosis pathway in peripheral blood mononuclear cells of patients with idiopathic inflammatory myopathies].

Phospho-MLKL Upregulation in Immune-Mediated Necrotizing Myopathy: Implications for Disease Pathophysiology and Diagnosis.

Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: Insights From an Italian Multicenter Cohort.

Paraneoplastic dermatomyositis with atypical features associated with a solid pseudopapillary pancreatic neoplasm.

Thrombotic microangiopathy in a patient with anti-signal recognition particle antibody-positive immune-mediated necrotising myopathy: a case report.

Extracellular Vesicular Proteins in Plasma from Patients with Cutaneous Lupus Correlate with Disease Activity.

Idiopathic Inflammatory Myopathy With Normal Creatine Kinase Levels in an Elderly Patient: A Diagnostic Challenge.

Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis.

Muscle RING finger-1 facilitates skeletal muscle regeneration via regulating myoblast proliferation and differentiation.

Hyperglycemia-A Driver of Cutaneous Severity in Dermatomyositis: A Narrative Review.

Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis.

Characteristics, treatments and outcomes of patients with dermatomyositis using real-world data.

A Diagnostic Delay: Respiratory Muscle Weakness in Dermatomyositis Masquerading as Pneumonia.

An Overview of Small-Molecule Agents for the Treatment of Dermatomyositis.

Kikuchi-Fujimoto Disease as the Initial Presentation of Dermatomyositis.

Different faces of anti-melanoma differentiation-associated gene 5 antibody-positive myositis.

Dysregulation of YTHDF2 promotes the over expression of interferon beta in anti-MDA5 antibody-positive dermatomyositis.

Comparison of disease severity and activity between juvenile- and adult-onset dermatomyositis: a multicentre cohort study.

Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

IgG from anti-MDA5⁺ CADM patients impairs NK cell function via CD16 in RP-ILD.

Intravitreal Clindamycin for Multifocal Toxoplasma Retinochoroiditis in Immunocompromised Patients: A Case Series with Aqueous Humor PCR Confirmation.

When viral infections meet the anti-MDA5 antibody-positive dermatomyositis.

From Rhabdomyolysis to a Lymphoproliferative Disorder: A Long Diagnostic Work-Up.

Serum ferritin trajectories predict mortality risk in anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis: a longitudinal cohort study.

An Unusual Case of Juvenile Dermatomyositis Complicated by Macrophage Activation Syndrome.

Alterations of mucosal-associated invariant T cells in dermatomyositis.

Comparison of pre- and post-natal environmental exposures in United States versus Brazilian patients with juvenile dermatomyositis.

Marked Long-Term Improvement in Lung Function in Melanoma Differentiation-Associated Protein 5 Antibody-Positive Dermatomyositis Patients: Experience of a Single-Center Longitudinal Cohort in North America.

Post-COVID-19 Inflammatory Myopathy With Dermatomyositis-Mixed Connective Tissue Disease (MCTD) Overlap Features and Epiglottitis: A Case Report.

Stevens-Johnson syndrome/toxic epidermal necrolysis as the initial presentation of paraneoplastic anti-TIF1-γ dermatomyositis.

Dermatomyositis and Polymyositis: Are Both Ends of a Same Spectrum?

Clinical prognosis and cancer risk assessment in autoimmune diseases with anti-TIF1γ alone or concurrent with anti-Ro52 antibodies in a Taiwanese cohort.

Lenabasum, a cannabinoid type 2 receptor agonist, exerts anti-inflammatory effects in dermatomyositis.

A Case of Antinuclear Antibody-Negative Dermatomyositis with Interstitial Lung Disease.

JAK Inhibition Restores Epidermal Homeostasis and Modulates Immune Responses in Dermatomyositis Skin: A Spatial Transcriptomic Pilot Study.

Sex Differences in PROMIS Pediatric Depressive Symptoms, Anxiety, and Psychological Stress Among Children and Adolescents Living With Pediatric Rheumatic Diseases.

The clinical values of laboratory inflammatory and composite indices in predicting rapidly progressive interstitial lung disease and prognosis in anti-MDA5 dermatomyositis patients.

The Refractory DermatoMyositis Index (ReDMI): a clinical tool to predict refractory disease in patients with dermatomyositis.

Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis.

Dermatomyositis following COVID-19 Vaccination: A Case Report and Review of Vaccine-associated Autoimmune Phenomena.

[Interferon scores in the management of rheumatic systemic diseases].

Immunotherapies in autoimmune inflammatory myopathies: Rationale and therapeutic updates.

Intravenous immunoglobulin use in neurology.

Semiquantitative HRCT scoring: a reliable predictor of rapidly progressive interstitial lung disease in patients with anti-MDA5 positive dermatomyositis.

Evaluating heterogeneity in MDA-5+ dermatomyositis through cluster analyses.

Energy-Based Devices for the Treatment of Cutaneous Lesions in Patients With Lupus Erythematosus and Dermatomyositis.

Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissue.

Risk Factors Associated with the Development of Thrombotic Microangiopathy in Patients with Dermatomyositis.

Peripheral blood immunophenotypic diversity in patients with anti-MDA5+ dermatomyositis and its impact on prognosis.

NXP-2-positive dermatomyositis presenting with pronounced unilateral lower extremity subcutaneous edema.

Prolonged remission of dermatomyositis and autoantibody negativization following SARS-CoV-2 infection in an elderly patient.

Validation of International Classification of Diseases Codes for Dermatologic Conditions: A Systematic Review.

Interferon-β Triggers Z-DNA Binding Protein 1-Mediated PANoptosis in T Cells of Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Dermatomyositis.

Unmasking inflammation in juvenile dermatomyositis: myokine profiles of patients and bioengineered human muscle.

Pregnancy outcomes in idiopathic inflammatory myopathies: a Portuguese multicentre study.

Nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases.

CTRP1 regulates skeletal muscle differentiation through quality control of mitochondrial dynamics and function.

Anti-MDA5 antibody-positive interstitial lung disease without prominent skin or muscle manifestations: A high-risk and potentially overlooked subgroup.

Baricitinib alleviates myositis-associated interstitial lung disease in mice by inhibiting the NETs-cGAS-STING-EMT axis.

Rituximab for Early-Onset Juvenile Dermatomyositis Complicated by Interstitial Lung Disease.

Identifying immunostimulatory herbal supplements that may flare autoimmune skin diseases: a systematic scoping review.

Paraneoplastic dermatomyositis with Kaposi's sarcoma: A case report.

Genetic Association Between Polymyositis/Dermatomyositis and Epilepsy: Insights From Mendelian Randomization and Bioinformatic Analyses.

Paraneoplastic Amyopathic Dermatomyositis Suspect by Nailfold Capillaroscopy in a Patient With Breast Carcinoma.

Flagellate Erythema: An Indicator of Underlying Malignancy in Dermatomyositis.

Transcriptomic signatures in different tissues of anti-MDA5 positive dermatomyositis: Uncovering genes with predictive potential for RP-ILD.

Concurrent paraneoplastic dermatomyositis and Sweet syndrome.

Dermatomyositis is characterized by JAK1-mediated monocyte-driven vasculopathy and inflammation.

An Update on Dermatomyositis and Related Inflammatory Myopathies: Cutaneous Clues, Skeletal Muscle Involvement, and Advances in Pathogenesis and Treatment.

Exhaustion of NK cells and interferon activation in anti-MDA5+ dermatomyositis are associated and determine the development of ILD.

Macrophage activation syndrome and rapidly progressive lung disease as life-threatening manifestations of anti-MDA5 antibody disease. A case report.

Unraveling the genetic association between autoimmune thyroid diseases and idiopathic inflammatory myopathies in the European population.

Sit to stand and timed up and go in idiopathic inflammatory myopathies.

Dermatomyositis in women: a 15-year retrospective analysis of clinical patterns, malignancy risk, and long-term outcomes at a tertiary center.

Case Report: Low-Dose Tofacitinib Reverses Progressive Interstitial Lung Disease in Anti-MDA5 Dermatomyositis After Failure of Traditional Immunosuppression.

A Comparative Bibliometric Analysis of Pediatric Interstitial Lung Disease Treatment: Global Trends, Advances, and Future Directions (2004-2024).

Concomitant IgA nephropathy and dermatomyositis: a case-based review.

Serum Autoantibodies in Dermatomyositis and Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.

Juvenile dermatomyositis as a rare paraneoplastic manifestation of nasopharyngeal carcinoma.

Critical Limb Ischaemia in a Patient With Subcutaneous Nodules: Clues to a Hidden Systemic Disease.

Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study.

[Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease].

[Rheumatic disease spectrum and immunological profile of anti-PM/Scl antibodies in idiopathic inflammatory myopathies].

Corrigendum to "Diagnosis of neuropsychiatry disorder in patients with anti-MDA5 antibody dermatomyositis: A case report" [Heliyon Volume 9, Issue 12, December 2023, Article e22935].

Efficacy of anifrolumab on skin, joint and lung involvement in anti-MDA5 positive dermatomyositis: a case report.

Clinical use of intravenous immunoglobulin in juvenile dermatomyositis: indications, treatment course, and clinical outcomes.

Association of dermatological manifestations with in fertility: A systematic review of literature.

Drooling as a Red Flag: Insights From a Case Series in Severe Dermatomyositis With Literature Review.

CaNO and eCO Might Be Potential Non-Invasive Biomarkers for Disease Severity and Exacerbations in Interstitial Lung Disease.

New-onset anti-melanoma differentiation-associated gene 5 antibody positive clinically amyopathic dermatomyositis following COVID-19: A case report.

RF-New Treatments in Dermatomyositis: Present and Future.

MDA5 Antibody Associated Juvenile Dermatomyositis Presenting as Rapidly Progressive Pulmonary Fibrosis-Case Report.

Artifactual hypoglycemia caused by Raynaud's phenomenon: A case report with literature review.

Unilateral Facial Swelling as the Inaugural Sign of Anti-NPX2 Dermatomyositis: A Diagnostic Challenge in Oral Medicine.

Cardiac involvement in patients with anti-MDA5 Ab+ dermatomyositis: a cross-sectional study with cardiac magnetic resonance.

Prognostic factors and a nomogram for survival in anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease.

Muscle mitochondrial changes in antisynthetase syndrome and other idiopathic inflammatory myopathies.

Musculoskeletal Diseases: Mechanisms and Therapeutic Advances.

Predictive role of muscle MRI in juvenile dermatomyositis: A tertiary center experience.